1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with isoquinoline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bossemeyer, D; Engh, RA; Girod, A; Huber, R; Kinzel, V | 1 |
Adam, J; Black, D; Boucharens, S; Brown, AR; de Man, J; Epemolu, O; Fletcher, D; Huggett, M; Jones, P; Laats, S; Lyons, A; Morphy, R; Ray, P; Sherborne, B; Sherry, L; Straten, Nv; Westwood, P; Wright, J; York, M | 1 |
Barroso, RCR; Bastos, ITS; Costa, FN; Fernandes, PD; Ferreira, FF; Fraga, CAM; Guerra, FS; Mermelstein, CDS; Oliveira, RG | 1 |
3 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and isoquinoline
Article | Year |
---|---|
Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Binding Sites; Casein Kinase II; Casein Kinases; Cattle; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Glycine; Isoquinolines; Myosin-Light-Chain Kinase; Protein Conformation; Protein Kinase C; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Sulfonamides | 1996 |
Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amines; Animals; Disease Models, Animal; Hypertension; Isoquinolines; Models, Chemical; Models, Molecular; Piperidines; Protein Kinase Inhibitors; Quinolones; Rats; rho-Associated Kinases; Structure-Activity Relationship | 2011 |
Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cell Line, Tumor; Female; Humans; Hydrazones; Isoquinolines; Models, Molecular; Powder Diffraction; Protein Kinase Inhibitors; rho-Associated Kinases; Spectrum Analysis | 2018 |